Diabetic complications within ocular surface;Powikłania cukrzycowe w obrȩbie powierzchni oka

Polski Merkuriusz Lekarski

Volumn 21, Issue 125, 2006, Pages 495-497

  Wylȩgała, Edward ^a,b,d,e   Moćko, Lucyna ^c,d   Woyna Orlewicz, Anna ^b,d   Teper, Sławomir ^b,d   Orzechowska WylȩgaŁa, Bogusława ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Oddzia Okulistyczny   (Poland)

^c Wojewódzka Poradnia Okulistyczna W Katowicach   (Poland)

^d District Railway Hospital in Katowice   (Poland)

^e Ophthalmology Department ^*  (Poland)

Author keywords

Diabetes; Keratoepitheliopathy; Ocular surface

Indexed keywords

ASCORBIC ACID; DEXPANTHENOL; RETINOL; RETINOL PALMITATE;

CONJUNCTIVA DISEASE; CORNEA DISEASE; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; EYE SURGERY; FUNCTIONAL DISEASE; HUMAN; PATHOGENESIS; REVIEW;

EID: 33845345248     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Alvarenga L., Martins E., Grottone G. i wsp.: Usefulness of corneal estesiometry for screening diabetic retinopathy. Rev. Saude Publica., 2003, 37(5), 609-15.
2. Dogru M., Katakami C., Inoue M.: Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology, 2001, 108(3), 586-92.
3. Goebbels M.: Tear secretion and tear film function in insulin dependent diabetics. Br. J. Ophthalmol., 2000, 84, 19-21.
4. Hosotani H., Ohashi Y., Yamada M. i wsp.: Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patinets by aldose reductase inhibitor, CT 112. Am. J. Ophthalmol., 1995, 119, 228-94.
5. Inoue K., Kato S., Ohara C. i wsp.: Ocular and systemic factors relevant to diabetic keratoepitheliopathy. Cornea, 2001, 20(8), 798-801.
6. Ishida N., Rao G., Cerro M. i wsp.: Corneal nerve alterations in diabetes mellitus. Arch. Opthalmol., 1984, 102, 1380-4.
7. Jalbert I., Stapleton F., Papas E. i wsp.: In vivo confocal microscopy of the human cornea. Br. J. Ophthalmol., 2003, 87, 225-36.
8. Kador P., Kinoshita J.: Role of aldose reductase in the development of diabetes-associated complications. Am. J. Med., 1985, 79 supl 5A, 8-12.
9. Kaji Y., Usui T., Oshika T. i wsp.: Advanced glication endproducts in diabetic corneas. Invest. Ophthalmol. Vis. Sci., 2000, 41, 362-8.
10. Kinoshita S., Kiorpes T., Friend J. i wsp.: Goblet cell density in ocular surface disease. Arch. Ophthalmol., 1983, 101, 1284-7.
11. Lauritzen T., Larsen H., Frost-Larsen K. i wsp.: Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet, 1983, 29, 200-4.
12. McNamara N., Brand R., Polse K. i wsp.: Corneal function during normal and high serum glucose levels in diabetes. Invest. Ophthalmol. Vis. Sci., 1998, 39(1), 3-17.
13. Menchini U., Scialdone A., Pietroni C. i wsp.: Argon versus krypton panretinal photocoagulation side effects on the anterior segment. Ophthalmologica, 1990, 201, 66-70.
14. Nielsen N., Lund F., Diabetic polyneuropathy. Corneal sensitivity, vibratory perception and Achilles tendon reflex in diabetics. Acta. Neurol. Scandinav., 1979, 59, 15-22.
15. Olsen T., Busted N.: Corneal thickness in diabetes mellitus. Lancet, 1980, 1, 883.
16. Peponis V., Bonovas S., Kapranou A. i wsp.: Conjunctival and tear film changes after vit. C and E administration in non-insulin dependent diabetes mellitus. Med. Sci. Monit., 2004, 10(5), 213-7.
17. Peponis V., Papathanasiou M., Kapranou A. i wsp.: Protective role of oral antioxidant supplementation in ocular surface of diabetic patients. Br. J. Ophthalmol., 2002, 86, 1369-73.
18. Riss B., Binder S.: Die Hornhautsensibilitat nach Lichtkoagulation bei diabetischer Retinopatie. Graefe's Arch. Klin. Exp. Ophthalmol., 1981, 217(2), 143-7.
19. Rogell G.D.: Corneal hypestesia and retinopathy in diabetes mellitus. Ophthalmology. 1980, 87, 229-33.
20. Rogel G.D.: Internal ophthalmoplegia after argon laser panretinal photocoagulation. Arch. Ophthalmol., 1979, 97, 904-905.
21. Rosenberg M., Tervo T., Immonen I. i wsp.: Corneal structure and sensitivity in type I diabetess mellitus. Invest. Ophthalmol. Vis. Sci., 2000, 41, 2915-21.
22. Ruben S.: Corneal sensation in insulin dependent and non-insulin dependent diabetics with proliferative retinopathy. Acta Ophthalmol., 1994, 72, 576-80.
23. Sato E., Mori F., Igarashi S. I wsp.: Corneal advanced glication end products increase in patients with proliferative diabetic retinopathy. Diabetes Care. 2001, 24, 479-82.
24. Schiodte S.N.: Effects on choroidal nerves after panretinal Xenon arc and argon laser photocoagulation. Acta Ophthalmol., 1984, 62, 244-55.
25. Schultz R., Matsuda M., Yee R. i wsp.: Corneal endothelial changes in type I and II diabetes mellitus. Am. J. Ophthalmol., 1984, 98(4), 401-410.
26. Tabatabay C., Bumbacher M., Baumgartner B. i wsp.: Reduced number of hemidesmosomes in corneal epithelium of diabetics with proliferative vitreoretinopathy. Graefe's Arch. Clin. Exp. Ophthalmol., 1988, 226, 389-92.
27. Tseng S.C.G.: Staging of coniunctival squamous metaplasia by impression cytology. Ophthalmology, 1985, 92(6), 728-733.
28. Wylȩgała E.: Chirurgiczne leczenie niewydolności ra̧bkowych komórek macierzystych rogówki w oparciu o najnowsze metody biologii molekularnej. Oftal, Warszawa, 2004, 18.